✦ LIBER ✦

Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non-Small-Cell Lung Cancer and a Performance Status of 2

✍ Scribed by Lilenbaum, R.; Axelrod, R.; Thomas, S.; Dowlati, A.; Seigel, L.; Albert, D.; Witt, K.; Botkin, D.

Book ID: 125520649
Publisher: American Society of Clinical Oncology
Year: 2008
Tongue: English
Weight: 205 KB
Volume: 26
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2007.13.2720

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomized Phase II Trial of Onartuzumab

Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Ervin, T. J.; Ramlau, R. A.; Daniel, D. B.; Goldschmidt, J. H.; B 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB

Randomized phase II trial of gefitinib o

Randomized phase II trial of gefitinib or gemcitabine or docetaxel chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2 or 3 (IFCT-0301 study)

✍ Morère, Jean-François; Bréchot, Jeanne-Marie; Westeel, Virginie; Gounant, Valeri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 483 KB

Randomized Phase II Trial of Erlotinib W

Randomized Phase II Trial of Erlotinib With and Without Entinostat in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed on Prior Chemotherapy

✍ Witta, S. E.; Jotte, R. M.; Konduri, K.; Neubauer, M. A.; Spira, A. I.; Ruxer, R 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 917 KB

A phase II trial of erlotinib in patient

A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer

✍ Takashi Kobayashi; Tomonobu Koizumi; Toshihide Agatsuma; Masanori Yasuo; Kenji T 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 271 KB

Randomized phase II study of gefitinib v

Randomized phase II study of gefitinib versus erlotinib in patients with advanced non-small cell lung cancer who failed previous chemotherapy

✍ Kim, Seung Tae; Uhm, Ji Eun; Lee, Jeeyun; Sun, Jong-mu; Sohn, Insuk; Kim, Seon W 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 359 KB

Randomized Phase III Trial of Erlotinib

Randomized Phase III Trial of Erlotinib Versus Docetaxel As Second- or Third-Line Therapy in Patients With Advanced Non-Small-Cell Lung Cancer: Docetaxel and Erlotinib Lung Cancer Trial (DELTA)

✍ Kawaguchi, T.; Ando, M.; Asami, K.; Okano, Y.; Fukuda, M.; Nakagawa, H.; Ibata, 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 183 KB